MR [Mindray Medical International] 6-K: Mindray Announces First Quarter 2011 Financial Results Shenzhen,

[Mindray Announces First Quarter 2011 Financial Results Shenzhen, China May9, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March31, 2011. Highlights for First Quarter 2011 Net revenues were $180.9million, anrease of 24.0% over the]

MR [Mindray Medical International] 6-K: Mindray Announces First Quarter 2011 Financial Results Shenzhen,

[Mindray Announces First Quarter 2011 Financial Results Shenzhen, China May9, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March31, 2011. Highlights for First Quarter 2011 Net revenues were $180.9million, anrease of 24.0% over the]

MR [Mindray Medical International] 20-F/A: TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3

[TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3 EX-101 INSTANCE DOCUMENT EX-101HEMA DOCUMENT EX-101LCULATION LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EXPLANATORY NOTE No other changes have been made to the Form 20-F. This Amendment does not reflect events that have occurred after the April8, 2011 filingte of]

MR [Mindray Medical International] 20-F/A: TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3

[TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3 EX-101 INSTANCE DOCUMENT EX-101HEMA DOCUMENT EX-101LCULATION LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EXPLANATORY NOTE No other changes have been made to the Form 20-F. This Amendment does not reflect events that have occurred after the April8, 2011 filingte of]

DHRM [Dehaier Medical Systems] 10-Q: (Original Filing)

[] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [Certification of Principal Financial Officer I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Zheng (Rita) Liu Chief Financial Officer (Principal Financial Officer)]

DHRM [Dehaier Medical Systems] 10-Q:

[] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [Certification of Principal Financial Officer I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Zheng (Rita) Liu Chief Financial Officer (Principal Financial Officer)]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Files Annual Report on Form 20-F Investors may obtain a printed copy of Mindray’s audited financial statements free of charge by contacting Mindray Investor Relations either by phone, email or in writing at the addresses below: ATTN: Investor Relations About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen,]

MR [Mindray Medical International] 6-K: Mindray Files Annual Report on Form 20-F Investors

[Mindray Files Annual Report on Form 20-F Investors may obtain a printed copy of Mindray’s audited financial statements free of charge by contacting Mindray Investor Relations either by phone, email or in writing at the addresses below: ATTN: Investor Relations About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen,]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Files Annual Report on Form20-F Investors may obtain a printedpy of Mindrays audited financial statements free of charge byntacting Mindray Investor Relations either by phone, email or in writing at thedresses below: ATTN: Investor Relationsout Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen,]

MR [Mindray Medical International] 6-K: Mindray Files Annual Report on Form20-F Investors may

[Mindray Files Annual Report on Form20-F Investors may obtain a printedpy of Mindrays audited financial statements free of charge byntacting Mindray Investor Relations either by phone, email or in writing at thedresses below: ATTN: Investor Relationsout Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen,]

Skip to toolbar